The Eye of the Storm: COVID-19 Vaccination and the Eye.
The Eye of the Storm: COVID-19 Vaccination and the Eye.
复制标题
DOI:
10.1007/s40123-021-00415-5
复制
发表时间:
2022-03
影响因子:
3.3
通讯作者:
Agrawal R
中科院分区:
文献类型:
--
作者:
Ng XL;Betzler BK;Ng S;Chee SP;Rajamani L;Singhal A;Rousselot A;Pavesio CE;Gupta V;de Smet MD;Agrawal R
The COVID-19 pandemic has galvanized the global response towards the development of new vaccines based on novel technologies at an unprecedented pace. Since the widespread implementation of vaccination campaigns, case reports on vaccines' systemic side effects, including ocular manifestations, have emerged. Since administered vaccines are generally not able to cause the disease in the recipient, or induce an immune response against the pathogen, we hypothesize that the development of ocular phenomena post-COVID-19 vaccination may occur via an immune response elicited by the vaccine. Of many, the most common ocular adverse events include facial nerve palsy, central venous sinus thrombosis and acute anterior uveitis. These COVID-19 vaccine-induced ocular (CVIO) adverse events could resemble the ocular findings in some of the COVID-19 patients. This review will provide a comprehensive overview of published ocular side effects potentially associated with COVID-19 vaccination and serve as a springboard for further research into CVIO adverse events.
登录
查看更多内容
DOI:
10.1186/s13054-021-03572-y
发表时间:
2021-04-12
期刊:
Critical care (London, England)
影响因子:
--
作者:
Castelli GP;Pognani C;Sozzi C;Franchini M;Vivona L
通讯作者:
Vivona L
影响因子:
6
作者:
Armstrong L;Collin J;Mostafa I;Queen R;Figueiredo FC;Lako M
通讯作者:
Lako M
影响因子:
11.8
作者:
Baxter, Roger;Lewis, Edwin;Klein, Nicola P.
通讯作者:
Klein, Nicola P.
影响因子:
0.8
作者:
Chin, Daniel;Gan, Nicola Y.;Manghani, Mona
通讯作者:
Manghani, Mona
DOI:
10.15585/mmwr.mm7027e2
发表时间:
2021-07-09
期刊:
MMWR. Morbidity and mortality weekly report
影响因子:
--
作者:
Gargano JW;Wallace M;Hadler SC;Langley G;Su JR;Oster ME;Broder KR;Gee J;Weintraub E;Shimabukuro T;Scobie HM;Moulia D;Markowitz LE;Wharton M;McNally VV;Romero JR;Talbot HK;Lee GM;Daley MF;Oliver SE
通讯作者:
Oliver SE